Louis C. Bock, Director, 10% Owner at Orexigen Therapeutics, Inc. (OREX), sold 2,800 shares at $15.00 ($42K) on 2007-11-19, disclosed to the SEC on 2007-11-20.
Open-market sale of $42k OREX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.00 | 600 | $9K | 21.4% |
| 2 | $15.01 | 1,000 | $15K | 35.7% |
| 3 | $15.02 | 200 | $3K | 7.1% |
| 4 | $15.04 | 100 | $2K | 3.6% |
| 5 | $15.10 | 14 | $211 | 0.5% |
| 6 | $15.13 | 186 |
| $3K |
| 6.7% |
| 7 | $15.17 | 100 | $2K | 3.6% |
| 8 | $15.00 | 600 | $9K | 21.4% |
| Total | $15.02 avg | 2,800 | $42K | 100% |
| Filing → |
| OREX | BUY | 2014-11-13 | $151K | — | Filing → |
| ZGNX | BUY | 2011-09-22 | $2.5M | — | Filing → |
| HZNP | BUY | 2011-08-04 | $2.8M | — | Filing → |